Cardinal Capital Management Inc (Canada)’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Cardinal Capital Management Inc (Canada)'s BMY Position: Q4 2023 in Review
Cardinal Capital Management Inc (Canada) sold out of Bristol-Myers Squibb (BMY) in Q4 2023, closing a stake of 11,050 shares — an estimated $641K sold.
Cardinal Capital Management Inc (Canada) first reported a position in BMY in Q2 2018 and held it in 22 quarters. The position peaked at $978K in Q2 2022. 2,363 funds tracked by Wall St. Rank hold BMY as of Q4 2023.
- Cardinal Capital Management Inc (Canada) reported no remaining Bristol-Myers Squibb position as of Q4 2023 after selling out during the quarter.
- Cardinal Capital Management Inc (Canada) sold 11,050 Bristol-Myers Squibb shares in Q4 2023, an estimated $641K.
- Cardinal Capital Management Inc (Canada) first reported a position in Bristol-Myers Squibb in Q2 2018 and held it in 22 quarters.
- Cardinal Capital Management Inc (Canada)'s Bristol-Myers Squibb position peaked at $978K in Q2 2022.
- 2,363 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2023.
Based on Cardinal Capital Management Inc (Canada)'s 13F filing for Q4 2023, filed 23 Feb 2024.